Performance in Initiating and Delivering Clinical Research
The Government wishes to see a dramatic and sustained improvement in the performance of providers of NHS services in initiating and delivering clinical research. The aim is to increase the number of patients who have the opportunity to participate in research and to enhance the nation’s attractiveness as a host for research.
As part of the oversight of this aim, providers of NHS Services are required to publish information on recruitment to clinical trials and delivery to time and to target for commercial clinical trials.
The tables on this page include the latest reports on our performance in initiating and delivering research up to Q3 of the 2019/20 reporting year – 1 October 2019 to 31 December 2019. The reports cover a rolling 12 month period from 1 January 2019 to 31 December 2019.
Quarter 3 Reports
1st October to 30th December 2019
.TABLE 1 – Performance in Initiating Clinical Research Q2 2019/2020
Table 1 provides information about studies with a DATE SITE SELECTED that falls within the last 12 months. This applies to only Clinical Trials approved through the HRA systems. Clinical Trials approved under the old systems are now excluded. The table identifies where delays in set-up and recruitment of first patients have occurred, providing transparency of process. Where Sponsor expectations have not been met by the Trust, this information is recorded In the table.
TABLE 2 – Performance in Delivering Clinical Research Q2 2019/20 – Recruitment to Time and to Target
Table 2 provides information about commercially sponsored research hosted by Gloucestershire Health and Care NHS Foundation Trust in relation to meeting the time and target metric (HLO#2) and includes those studies that have closed in the last 12 months.
These reports will be updated on a quarterly basis.
If there are any questions about these reports or the benchmarks themselves, please contact Mark Walker, Head of Research and Development on 01242 634491 or email@example.com.